Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

ClinicalTrials.gov ID: NCT04007367

Public ClinicalTrials.gov record NCT04007367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 5:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-controlled Study of the Efficacy and Safety of SAGE-217 With a Fixed, Repeated Treatment Regimen on Relapse Prevention in Adults With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study with an Open-Label (OL) phase followed by a randomized, Double-Blind (DB), placebo-controlled phase to assess efficacy and safety of SAGE-217 on relapse prevention in adults with major depressive disorder (MDD).

Study identification

NCT ID
NCT04007367
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
53 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 6, 2019 (Actual)
Primary completion
Jan 6, 2020 (Actual)
Completion
Jan 6, 2020 (Actual)
Last update posted
Nov 29, 2023

2019 – 2020

United States locations

U.S. sites
46
U.S. states
19
U.S. cities
43
Facility City State ZIP Site status
Sage Investigational Site Bentonville Arkansas 72712 —
Sage Investigational Site Bellflower California 90706 —
Sage Investigational Site Garden Grove California 92845 —
Sage Investigational Site Lemon Grove California 91945 —
Sage Investigational Site Oceanside California 92056 —
Sage Investigational Site Orange California 92868 —
Sage Investigational Site Riverside California 92503 —
Sage Investigational Site San Diego California 92103 —
Sage Investigational Site San Marcos California 92078 —
Sage Investigational Site Sherman Oaks California 91403 —
Sage Investigational Site Coral Springs Florida 33067 —
Sage Investigational Site Jacksonville Florida 32256 —
Sage Investigational Site Lauderhill Florida 33319 —
Sage Investigational Site Orlando Florida 32801 —
Sage Investigational Site Alpharetta Georgia 30022 —
Sage Investigational Site Atlanta Georgia 30328 —
Sage Investigational Site Atlanta Georgia 30329 —
Sage Investigational Site Atlanta Georgia 30331 —
Sage Investigational Site Decatur Georgia 30030 —
Sage Investigational Site Chicago Illinois 60634 —
Sage Investigational Site Lincolnwood Illinois 60712 —
Sage Investigational Site Lake Charles Louisiana 70629 —
Sage Investigational Site Gaithersburg Maryland 20877 —
Sage Investigational Site Boston Massachusetts 02131 —
Sage Investigational Site Methuen Massachusetts 01844 —
Sage Investigational Site Watertown Massachusetts 02472 —
Sage Investigational Site Ann Arbor Michigan 48109 —
Sage Investigational Site Las Vegas Nevada 89102 —
Sage Investigational Site Berlin New Jersey 08009 —
Sage Investigational Site Cherry Hill New Jersey 08002 —
Sage Investigational Site Marlton New Jersey 08053 —
Sage Investigational Site Albuquerque New Mexico 87109 —
Sage Investigational Site Jamaica New York 11432 —
Sage Investigational Site New York New York 10017 —
Sage Investigational Site New York New York 10128 —
Sage Investigational Site Rochester New York 14618 —
Sage Investigational Site Dayton Ohio 454117 —
Sage Investigational Site North Canton Ohio 44720 —
Sage Investigational Site Oklahoma City Oklahoma 73106 —
Sage Investigational Site Allentown Pennsylvania 18104 —
Sage Investigational Site Memphis Tennessee 38119 —
Sage Investigational Site Austin Texas 78737 —
Sage Investigational Site Dallas Texas 75231 —
Sage Investigational Site Richardson Texas 75080 —
Sage Investigational Site Wichita Falls Texas 76309 —
Sage Investigational Site Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04007367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2023 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04007367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →